Zymeworks BC Inc (NASDAQ: ZYME) is 40.99% higher on its value in year-to-date trading and has touched a low of $9.03 and a high of $17.70 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The ZYME stock was last observed hovering at around $13.52 in the last trading session, with the day’s gains setting it 0.96%.
Currently trading at $14.48, the stock is 11.53% and 17.22% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.84 million and changing 7.10% at the moment leaves the stock 9.87% off its SMA200. ZYME registered -1.09% loss for a year compared to 6-month loss of 6.31%. The firm has a 50-day simple moving average (SMA 50) of $12.3091 and a 200-day simple moving average (SMA200) of $13.16235.
The stock witnessed a 14.47% gain in the last 1 month and extending the period to 3 months gives it a 32.36%, and is 6.00% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.34% over the week and 4.03% over the month.
Zymeworks BC Inc (ZYME) has around 286 employees, a market worth around $1.02B and $93.38M in sales. Profit margin for the company is -121.73%. Distance from 52-week low is 60.35% and -18.19% from its 52-week high. The company has generated returns on investments over the last 12 months (-33.42%).
The EPS is expected to grow by 5.82% this year
267.0 institutions hold shares in Zymeworks BC Inc (ZYME), with institutional investors hold 102.97% of the company’s shares. The shares outstanding are 69.58M, and float is at 67.74M with Short Float at 10.22%. Institutions hold 102.81% of the Float.
The top institutional shareholder in the company is ECOR1 CAPITAL, LLC with over 13.44 million shares valued at $114.35 million. The investor’s holdings represent 17.59 of the ZYME Shares outstanding. As of 2024-06-30, the second largest holder is BVF INC/IL with 5.87 million shares valued at $49.95 million to account for 7.684 of the shares outstanding. The other top investors are REDMILE GROUP, LLC which holds 5.21 million shares representing 6.8214 and valued at over $44.35 million, while MORGAN STANLEY holds 5.5496 of the shares totaling 4.24 million with a market value of $36.08 million.
Zymeworks BC Inc (ZYME) Insider Activity
The most recent transaction is an insider purchase by EcoR1 Capital, LLC, the company’s Director. SEC filings show that EcoR1 Capital, LLC bought 49,502 shares of the company’s common stock on May 15 ’25 at a price of $11.43 per share for a total of $0.57 million. Following the purchase, the insider now owns 17.88 million shares.
Zymeworks BC Inc disclosed in a document filed with the SEC on May 19 ’25 that EcoR1 Capital, LLC (Director) bought a total of 5,919 shares of the company’s common stock. The trade occurred on May 19 ’25 and was made at $11.78 per share for $69738.0. Following the transaction, the insider now directly holds 17.88 million shares of the ZYME stock.
Still, SEC filings show that on Apr 16 ’25, EcoR1 Capital, LLC (Director) acquired 73,953 shares at an average price of $11.16 for $0.83 million. The insider now directly holds 17,773,727 shares of Zymeworks BC Inc (ZYME).
